Front Row Advisors’s Arbutus Biopharma ABUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.4K | Hold |
10,500
| – | – | 0.01% | 242 |
|
|
2025
Q1 | $36.6K | Hold |
10,500
| – | – | 0.01% | 241 |
|
|
2024
Q4 | $34.3K | Hold |
10,500
| – | – | 0.01% | 250 |
|
|
2024
Q3 | $40.4K | Hold |
10,500
| – | – | 0.01% | 237 |
|
|
2024
Q2 | $32.4K | Hold |
10,500
| – | – | 0.01% | 326 |
|
|
2024
Q1 | $27.1K | Hold |
10,500
| – | – | 0.01% | 341 |
|
|
2023
Q4 | $26.3K | Hold |
10,500
| – | – | 0.01% | 228 |
|
|
2023
Q3 | $21.3K | Hold |
10,500
| – | – | 0.01% | 371 |
|
|
2023
Q2 | $24K | Hold |
10,500
| – | – | 0.01% | 339 |
|
|
2023
Q1 | $32K | Hold |
10,500
| – | – | 0.02% | 292 |
|
|
2022
Q4 | $24K | Hold |
10,500
| – | – | 0.01% | 338 |
|
|
2022
Q3 | $20K | Hold |
10,500
| – | – | 0.01% | 376 |
|
|
2022
Q2 | $28K | Hold |
10,500
| – | – | 0.01% | 315 |
|
|
2022
Q1 | $31K | Buy |
+10,500
| New | +$31K | 0.01% | 324 |
|